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A. phagocytophilum infection 
has been reported in I. persulcatus 
and engorged D. silvarum ticks in 
northeastern China (3). In this study, 
we also found Haemaphysalis spp. 
ticks, including H. longicornis and 
H. concinna ticks, to be infected by 
the agent. This fi nding indicates that 
various tick species may be involved 
in the maintenance and transmission 
of A. phagocytophilum. Both H. 
longicornis and H. concinna ticks 
usually have 3 hosts in their life cycle 
and can infest a variety of wild and 
domestic animals such as rodents, deer, 
scaly anteaters, sheep, goats, and dogs. 
Haemaphysalis ticks are distributed in 
a broad range of China and sometimes 
feed on humans. Their competency 
as a vector for A. phagocytophilum 
and the importance of this agent in 
public health as well as in veterinary 
medicine has yet to be investigated, 
particularly in the areas where they are 
predominant (9). The gltA sequence 
analyses indicated that the agents 
detected in this study were similar to 
the strains isolated from rodents and 
sheep in northeastern China (4) and 
to A. phagocytophilum strains from 
the Russian Far East adjacent to our 
survey sites. However, the strains 
from China are genetically distant 
from A. phagocytophilum strains in the 
United States and Europe. The genetic 
diversity of A. phagocytophilum in 
various geographic locations deserves 
further study.
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To the Editor: Tibet is located in 
the Qinghai-Tibet Plateau of western 
People’s Republic of China and 
has been internationally recognized 
as a Japanese encephalitis (JE)–
nonendemic area because the average 
altitude is thought to be too high 
to facilitate the cycle of Japanese 
encephalitis virus (JEV) between 
mosquitoes and vertebrates (1,2). In 
addition, JE is a reportable infectious 
disease in China, and no clinically 
confi rmed case has been reported in 
Tibet since establishment of a national 
case reporting system in 1951 (3,4). 
Neither the mosquito vector of JEV 
nor JEV isolates have been described 
in Tibet. In this study, JEV was 
isolated from Culex tritaeniorhynchus 
mosquitoes, the main vectors of JEV, 
collected in Tibet. Serologic assays 
detected anti-JEV antibodies in a large 
number of human and porcine serum 
samples collected in this region. These 
data demonstrate that JEV is currently 
circulating in Tibet.
During August 5–15, 2009, 
mosquitoes were collected in Mainling 
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County (altitude 2,900 m) and Medog 
County (altitude 1,000 m) in the 
Nyingchi area of Tibet. A total of 4,089 
mosquitoes representing 7 species (Cx. 
tritaeniorhynchus, Cx. pipiens pallens, 
Cx. bitaeniorhynchus, Armigeres 
obturbans, Anopheles maculatus 
maculates, An. peditaeniatu, and 
Aedes albopictus) from 4 genera were 
collected in this study. The dominant 
mosquito species detected in Medog 
County was Cx. tritaeniorhynchus 
(2,442 [71.1%] of 3,436 mosquitoes 
collected there) (Table); no previous 
reports have described this species 
in Tibet. A total of 653 mosquitoes 
were collected in Mainling County, of 
which 489 (74.9%) were Armigeres 
obturban. No Cx. tritaeniorhynchus 
mosquitoes were collected in Mainling 
County.
Mosquitoes were homogenized 
in 97 pools by using TissueLyser 
(QIAGEN, Hilden, Germany) and 
screened with reverse transcription–
PCR (RT-PCR) by using seminested 
primers designed to detect the 
JEV PreM gene (5). One Cx. 
tritaeniorhynchus pool, XZ0938, 
collected in Medog County was 
positive by PCR. Isolation of virus was 
conducted from PCR-positive sample 
by injecting mosquito homogenate 
supernatants into monolayers of BHK-
21 and C6/36 cells. The supernatant 
of pool XZ0938 caused cytopathic 
effects in BHK-21 and C6/36 cells 
in successive cell passages. The 
complete genome of 10,965 nt was 
sequenced (GenBank accession no. 
HQ652538) as described (6), which 
included a 96-nt 5′ nontranslated 
region and a 570-nt 3′ nontranslated 
region. The single open reading frame 
coded for a polyprotein of 3,432 aa. 
Compared with the complete genome 
sequences of 62 known JEV isolates, 
the nucleotide sequence identity 
varied from 83.6% to 97.8% and 
amino acid sequence identity from 
94.9% to 99.7%. Phylogenetic trees 
derived from nucleotide sequences of 
the complete genome of JEV strains 
indicated that XZ0938 was a member 
of genotype I JEV. A more detailed 
analysis indicated that the Tibet JEV 
is most closely related to JEV isolates 
KV1899 (1999, Korea, AY316157), 
and JEV/sw/Mie/41/2002 (2002, 
Japan, AB241119) (data not shown).
To determine whether local 
residents were infected by JEV, 248 
human serum samples were collected 
in Mainling and Medog Counties 
from healthy persons. Neutralizing 
antibody against JEV was tested by 
90% plaque-reduction neutralization 
tests by using standard methods (7). 
Serum samples were tested with serial 
2-fold dilutions from 1 to 5. Diluted 
serum was mixed with equal volumes 
of culture medium containing JEV P3 
strain. The samples were considered 
positive when the neutralizing 
antibody titers >10. Sixty-eight 
positive samples were determined by 
90% plaque-reduction neutralization 
tests, which constituted 68 (27.4%) 
of all 248 serum samples. Twenty-
two (22.0%) of 100 and 46 (31.1%) 
of 148 serum samples in Mainling and 
Medog Counties, respectively, were 
positive (Table). Currently, the local 
population is not vaccinated against 
JEV (8) because Tibet is considered 
a JE-nonendemic area (1–4). The 
observation that 68 (27.4%) of 248 
serum samples from healthy humans 
contained neutralizing antibody 
against JEV at titers >10 suggests that 
this population is subject to substantial 
levels of subclinical JEV infection.
To determine the present situation 
of JEV infection in local pigs, we 
analyzed 66 serum samples collected 
from piglets 1–6 months of age in 
Mainling and Medog Counties; 
immunoglobulin M antibodies against 
JEV were detected by capture ELISA 
as described (9). That 22 (33.3%) of 
66 piglet serum samples were positive 
for immunoglobulin M against JEV 
suggested that local pigs have been 
newly infected by JEV in 2009 and 
have participated in the cycles of JEV 
in the local area (Table).
JE is a global public health issue 
that has spread to >20 countries in 
Asia (6,10). In this study, we present 
evidence that JEV has extended its 
geographic range to Tibet, a region 
that previously was believed to be 
free of JE because of its elevation. 
Factors such as global warming, 
increased pig farming, and increased 
tourism and transportation may have 
contributed to the emergence of JE in 
Tibet. Conditions in Tibet, including 
the presence of the primary vector 
(Cx. tritaeniorhynchus mosquitoes), 
abundant amplifi cation hosts (pig), 
and a naive population that has not 
been vaccinated against JEV, present 
the possibility for JE outbreaks. 
Increased surveillance for JE in this 
region is needed.
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Table. Results from testing of mosquitoes, humans, and pigs for JEV, Nyingchi area, Tibet, People’s Republic of China, 2009* 
Collection sites 







Neutralizing antibody titers 
against JEV >10, no. (%) 
No.
samples 
JEV IgM antibody 
positive, no. (%) 
Mainling County 653 0 100 22 (22.0) 30 17 (56.7) 
Medog County 3,436 2,442 (71.1)† 148 46 (31.1) 36 5 (13.9) 
Total 4,089 2,442 (59.7) 248 68 (27.4) 66 22 (33.3) 
*JEV, Japanese encephalitis virus; Ig, immunoglobulin. 
†Pool was positive for JEV by PCR. 
LETTERS
This work was supported by grants 
from the Ministry of Science and 
Technology, China (2003BA712A08-01; 
2008ZX10004-001; 2011CB504702); 
China–US CDC Cooperative Agreement 
U19-GH000004; and Development Grant 
of State Key Laboratory for Infectious 
Disease Prevention and Control 
(2008SKLID105).
Yi-Xing Li,1 Ming-Hua Li,1 
Shi-Hong Fu, Wei-Xin Chen, 
Qi-Yong Liu, Hai-Lin Zhang, Wa 
Da, Song-Lin Hu, 
Sang Dan La Mu, Ju Bai, 
Zun-Dong Yin, Hong-Yue Jiang, 
Yu-Hong Guo, Dun Zhu Duo Ji, 
Hui-Mei Xu, Ge Li, 
Gu Gu Cuo Mu, Hui-Ming Luo, 
Jing-Lin Wang, Jun Wang, 
Xiu-Min Ye, Zhuo Ma Yang Jin, 
Wei Zhang, Gui-Jun Ning, 
Huan-Yu Wang, Gui-Chang Li, 
Jian Yong, Xiao-Feng Liang, 
and Guo-Dong Liang
Author affi liations: National Immunization 
Programme, Chinese Center for Disease 
Control and Prevention, Beijing, People’s 
Republic of China (Y.-X. Li, Z.-D. Yin, H.-
M. Luo, G.-J. Ning, X.-F. Liang); Institute 
for Viral Disease Control and Prevention, 
Beijing (M.-H. Li, S.-H. Fu, W.-X. Chen, 
H.-Y. Jiang, J.-L. Wang, H.-Y. Wang, G.-D. 
Liang); National Institute for Communicable 
Disease Control and Prevention, Beijing 
(Q.-Y. Liu, Y.-H. Guo, J. Wang, G.-C. Li); 
Yunnan Institute of Endemic Disease 
Control and Prevention, Yunnan, People’s 
Republic of China (H.-L. Zhang); Tibet 
Center for Disease Control and Prevention, 
Tibet, People’s Republic of China (W. Da, 
D.Z.D. Ji, X.-M. Ye); Nyingchi Center for 
Disease Control and Prevention, Tibet (S.-
L. Hu, H.-M. Xu, Z.M.Y. Jin); Medog County 
Center for Disease Control and Prevention, 
Tibet, (S.D.L. Mu, G. Li, W. Zhang, J. Yong); 
Mainling County Center for Disease Control 
and Prevention, Tibet (J. Bai, G.G.C. Mu) 
DOI: 10.3201/eid1705.101417
1These authors contributed equally to this 
article.
References
  1.  International Travel and Health. Infectious 
diseases of potential risk for travelers. Ge-
neva: World Health Organization; 2010.
  2.  Brunette GW, Kozarsky PE, Magill AJ, 
Shlim DR. The pre-travel consultation. In: 
CDC health information for international 
travel, 2010 (the yellow book). New York: 
Elsevier; 2009. p. 19–241.
  3.  Gao X, Nasci R, Liang G. The neglected 
arboviral infections in mainland Chi-
na. PLoS Negl Trop Dis. 2010;4:e624. 
doi:10.1371/journal.pntd.0000624
  4.  Wang H, Li Y, Liang X, Liang G. Japanese 
encephalitis in mainland China. Jpn J In-
fect Dis. 2009;62:331–6.
  5.  Wang LH, Fu SH, Wang HY, Liang GD, 
Cheng JX, Jing HM, et al. Japanese en-
cephalitis outbreak, Yuncheng, China, 
2006. Emerg Infect Dis. 2007;13:1123–5.
  6. Solomon T, Ni H, Beasley DW, Ekkelen-
kamp M, Cardosa MJ, Barrett AD. 
Origin and evolution of Japanese en-
cephalitis virus in southeast Asia. J 
Virol. 2003;77:3091–8. doi:10.1128/
JVI.77.5.3091-3098.2003
  7.  Kuniholm MH, Wolfe ND, Huang CY, 
Mpoudi-Ngole E, Tamoufe U, LeBreton 
M, et al. Seroprevalence and distribution 
of Flaviviridae, Togaviridae, and Bunya-
viridae arboviral infections in rural Cam-
eroonian adults. [Erratum in: Am J Trop 
Med Hyg. 2006;75:371]. Am J Trop Med 
Hyg. 2006;74:1078–83.
  8.  Halstead SB. Japanese encephalitis. In: 
Artenstein AW, editor. Vaccines: a biogra-
phy. New York: Springer; 2010. p. 317–
34.
  9.  Cardosa MJ, Hah FL, Choo BH, Padma-
nathan S. Screening of pig sera for anti-
bodies to Japanese encephalitis virus us-
ing a dot enzyme immunoassay and IgM 
capture ELISA: comparison with the hem-
agglutination inhibition and plaque reduc-
tion neutralization tests. Southeast Asian J 
Trop Med Public Health. 1993;24:472–6.
10.  Erlanger TE, Weiss S, Keiser J, Utzinger 
J, Wiedenmayer K. Past, present, and 
future of Japanese encephalitis. Emerg 
Infect Dis. 2009;15:1–7. doi:10.3201/
eid1501.080311
Address for correspondence: Guo-Dong 
Liang, State Key Laboratory for Infectious 
Disease Prevention and Control, Institute for 
Viral Disease Control and Prevention, Chinese 
Center for Disease Control and Prevention, 100 
Yingxin St., Xuanwu District, Beijing 100052, 
People’s Republic of China; email: gdliang@
hotmail.com
Babesia sp. EU1 
Infection in a 
Forest Reindeer, 
the Netherlands
To the Editor: Fatal piroplasmosis 
in domestic reindeer (Rangifer spp.) 
was fi rst reported by Kertzelli in 1909; 
he named the piroplasm Piroplasma 
tarandi rhangferis. Similar piroplasms 
also were observed in blood smears of 
reindeer that had a condition known as 
spleen disease, which occurred in the 
second part of summer in the Arctic 
tundra and was characterized by 
clinical signs such as splenomegaly, 
icterus, pale mucous membranes, 
and death (1). Hemoglobinuria, a 
characteristic sign of babesiosis, is not 
mentioned in these early 20th century 
reports. However, these signs were 
observed in a Babesia divergens–
infected reindeer herd in Scotland (2).
The only other reported cases 
of severe babesiosis in reindeer and 
caribou (Rangifer tarandus caribou) 
were caused by B. odocoilei, a 
predominantly nonpathogenic parasite 
of white-tailed deer (Odocoileus 
virginianus) that can cause fatal 
infection in reindeer (3,4). Babesia 
sp. EU1 is a recently recognized 
zoonotic Babesia species that has been 
associated with human babesiosis in 
Europe and is phylogenetically related 
to the B. odocoilei parasite (5). We 
report on a juvenile reindeer with 
babesiosis caused by Babesia sp. EU1.
A 5-week-old, captive-bred, 
female forest reindeer from an 
otherwise healthy herd of 9 animals 
in a zoo in the Netherlands was 
euthanized after showing clinical 
signs of lethargy, jaundice, and 
hemorrhagic diarrhea for >8 hours 
that did not improve after treatment 
with butylscopolamine (Buscopan; 
Boehringer Ingelheim, Alkmaar, 
the Netherlands) and enrofl oxacin 
(Baytril; Bayer, Leverkusen, 
Germany). At necropsy, jaundice 
was evident in the sclera, aorta, and 
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